The tumour inhibitory mechanism of LINC00312 was supposed to down-regulate the expression of oestrogen receptor alpha (ER-alpha) by regulating the JNK2/AP-1/MMP1 pathway [24]. Here, MAPK9 is linked to neoplasm.